| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.2.A
McLin VA et al. (2007)
|
Xla Wt + Mmu.lef1-Mmu.ctnnb1-GR + DEX
NF35/36 (in situ hybridization)
|
|
|
|
|
Fig.2.A
McLin VA et al. (2007)
|
Xla Wt + Mmu.lef1-Mmu.ctnnb1-GR + DEX
NF35/36 (in situ hybridization)
|
|
|
|
Fig.7.F
McLin VA et al. (2007)
|
Xla Wt + ventx2.2
NF35/36 (in situ hybridization)
|
|
|
|
Fig.S.2.C
McLin VA et al. (2007)
|
Xla Wt + VP16-ventx2.2-GR + DEX
NF35/36-37 and 38 (in situ hybridization)
|
|
|
|
|
Fig.S.2.C
McLin VA et al. (2007)
|
Xla Wt + VP16-ventx2.2-GR + DEX
NF35/36-37 and 38 (in situ hybridization)
|
|
|
|
|
Fig.S.2.C
McLin VA et al. (2007)
|
Xla Wt + VP16-ventx2.2-GR + DEX
NF35/36-37 and 38 (in situ hybridization)
|
|
|
|
|
Fig.S.2.C
McLin VA et al. (2007)
|
Xla Wt + VP16-ventx2.2-GR + DEX
NF35/36-37 and 38 (in situ hybridization)
|
|
|
|
Fig.1.B
McLin VA et al. (2007)
|
Xla Wt + wnt8a
NF35/36 (in situ hybridization)
|
|
|